Eisai Co., Ltd. announced today the company will present the latest findings from its Alzheimer's disease (AD) research, including lecanemab (brand name: LEQEMBI®), our anti-amyloid beta (A?) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results